Johnson DH - Search Results

1

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.

Waits TM, Johnson DH, Hainsworth JD, Hande KR, Thomas M, Greco FA. Waits TM, et al. Among authors: johnson dh. J Clin Oncol. 1992 Feb;10(2):292-6. doi: 10.1200/JCO.1992.10.2.292. J Clin Oncol. 1992. PMID: 1310104 Clinical Trial.

2

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer.

Murphy PB, Hainsworth JD, Greco FA, Hande KR, DeVore RF, Johnson DH. Murphy PB, et al. Among authors: johnson dh. Cancer. 1992 Jan 15;69(2):370-5. doi: 10.1002/1097-0142(19920115)69:2<370::aid-cncr2820690217>3.0.co;2-e. Cancer. 1992. PMID: 1309432 Clinical Trial.

3

Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.

Greco FA, Murphy PB, Hainsworth JD, Hande KR, Johnson DH. Greco FA, et al. Among authors: johnson dh. Oncology. 1992;49 Suppl 1:34-8; discussion 39. doi: 10.1159/000227108. Oncology. 1992. PMID: 1323810 Clinical Trial.

4

Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

Johnson DH, Hainsworth JD, DeVore R, Hande KR, Greco FA. Johnson DH, et al. Oncology. 1992;49 Suppl 1:57-61; discussion 61-2. doi: 10.1159/000227112. Oncology. 1992. PMID: 1323813 Clinical Trial.

5

Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.

Johnson DH, DeVore R, Greco FA, Walls J, Thomas M, Hande KR, Hainsworth JD. Johnson DH, et al. Semin Oncol. 1992 Feb;19(1 Suppl 2):50-6. Semin Oncol. 1992. PMID: 1329223 Clinical Trial.

6

Combination chemotherapy with oral etoposide.

Johnson DH, Hainsworth JD, Hande KR, Greco FA. Johnson DH, et al. Semin Oncol. 1992 Dec;19(6 Suppl 14):19-24. Semin Oncol. 1992. PMID: 1336896 Clinical Trial.

7

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.

Hainsworth JD, Johnson DH, Greco FA. Hainsworth JD, et al. Among authors: johnson dh. J Clin Oncol. 1992 Jun;10(6):912-22. doi: 10.1200/JCO.1992.10.6.912. J Clin Oncol. 1992. PMID: 1375284

8

The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.

Hainsworth JD, Johnson DH, Greco FA. Hainsworth JD, et al. Among authors: johnson dh. Semin Oncol. 1992 Apr;19(2 Suppl 5):54-7; discussion 58. Semin Oncol. 1992. PMID: 1384145

9

Chronic etoposide schedules in the treatment of non-Hodgkin's lymphoma.

Hainsworth JD, Johnson DH, Greco FA. Hainsworth JD, et al. Among authors: johnson dh. Semin Oncol. 1992 Dec;19(6 Suppl 14):13-8. Semin Oncol. 1992. PMID: 1488651 Clinical Trial.

10

Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.

Greco FA, Johnson DH, Hainsworth JD. Greco FA, et al. Among authors: johnson dh. Semin Oncol. 1992 Dec;19(6 Suppl 13):14-8. Semin Oncol. 1992. PMID: 1492223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters